| 000 | 01658 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517225009.0 | ||
| 264 | 0 | _c20190626 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1098-660X | ||
| 024 | 7 |
_a10.1128/JCM.00717-18 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBailey, Adam L | |
| 245 | 0 | 0 |
_aMulticenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _c09 2018 |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCephalosporins _xpharmacology |
| 650 | 0 | 4 |
_aDisk Diffusion Antimicrobial Tests _xmethods |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
| 650 | 0 | 4 |
_aEnterobacteriaceae _xdrug effects |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPseudomonas Infections _xmicrobiology |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTazobactam _xpharmacology |
| 700 | 1 | _aArmstrong, Tom | |
| 700 | 1 | _aDwivedi, Hari-Prakash | |
| 700 | 1 | _aDenys, Gerald A | |
| 700 | 1 | _aHindler, Janet | |
| 700 | 1 | _aCampeau, Shelley | |
| 700 | 1 | _aTraczewski, Maria | |
| 700 | 1 | _aHumphries, Romney | |
| 700 | 1 | _aBurnham, C A | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 56 _gno. 9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.00717-18 _zAvailable from publisher's website |
| 999 |
_c28602785 _d28602785 |
||